Subcutaneous foslevodopa foscarbidopa infusion improves control in Parkinson’s disease
An RCT has found that subcutaneous foslevodopa foscarbidopa improved symptom control in advanced Parkinson’s disease compared to oral therapy
A subcutaneous infusion of foslevodopa and foscarbidopa to patients with advanced Parkinson’s…